Liquidia Corporation
General ticker "LQDA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.4B (TTM average)
Liquidia Corporation follows the US Stock Market performance with the rate: 54.3%.
Estimated limits based on current volatility of 3.0%: low 31.84$, high 33.82$
Factors to consider:
- Total employees count: 168 as of 2024
- Top business risk factors: Insufficient funding, Product liability, Supply chain disruptions, Operational and conduct risks, Commercialization challenges
- Current price 140.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.24$, 14.13$]
- 2025-12-31 to 2026-12-31 estimated range: [5.29$, 12.21$]
Financial Metrics affecting the LQDA estimates:
- Negative: with PPE of -6.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.47 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 33.55 <= 41.86
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -4.48 < Investing cash flow per share per price, % of -0.95
- Positive: Interest expense per share per price, % of 1.40 <= 3.41
- Negative: negative Industry operating cash flow (median)
Short-term LQDA quotes
Long-term LQDA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.94MM | $17.49MM | $14.00MM |
| Operating Expenses | $54.70MM | $90.87MM | $135.29MM |
| Operating Income | $-38.77MM | $-73.38MM | $-121.29MM |
| Non-Operating Income | $-2.25MM | $-5.12MM | $-9.10MM |
| Interest Expense | $2.34MM | $6.27MM | $12.49MM |
| R&D Expense | $19.43MM | $43.24MM | $47.84MM |
| Income(Loss) | $-41.02MM | $-78.50MM | $-130.39MM |
| Profit(Loss)* | $-41.02MM | $-78.50MM | $-130.39MM |
| Stockholders Equity | $90.42MM | $47.29MM | $77.28MM |
| Inventory | $0.00MM | $0.00MM | $0.24MM |
| Assets | $129.20MM | $118.33MM | $230.31MM |
| Operating Cash Flow | $-28.59MM | $-41.56MM | $-93.42MM |
| Capital expenditure | $0.59MM | $1.29MM | $4.95MM |
| Investing Cash Flow | $-0.59MM | $-11.29MM | $-8.44MM |
| Financing Cash Flow | $64.96MM | $43.25MM | $194.66MM |
| Earnings Per Share** | $-0.67 | $-1.21 | $-1.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.